Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities.

Marco Carotenuto, Michele Roccella, Francesco Pisani, Sara Matricardi, Alberto Verrotti, Giovanni Farello, Francesca Felicia Operto, Ilaria Bitetti, Francesco Precenzano, Giovanni Messina, Maria Ruberto, Cristiana Ciunfrini, Mariagrazia Riccardi, Eugenio Merolla, Grazia Maria Giovanna Pastorino, Anna Nunzia Polito, Rosa Marotta

Journal: Behavioural neurology 2020;2019():5202808

PMID: 31885726

Abstract

Fragile X syndrome (FXS) is a genetic syndrome with intellectual disability due to the loss of expression of the FMR1 gene located on chromosome X (Xq27.3). This mutation can suppress the fragile X mental retardation protein (FMRP) with an impact on synaptic functioning and neuronal plasticity. Among associated sign and symptoms of this genetic condition, sleep disturbances have been already described, but few polysomnographic reports in pediatric age have been reported. This multicenter case-control study is aimed at assessing the sleep macrostructure and at analyzing the presence of EEG abnormalities in a cohort of FXS children. We enrolled children with FXS and, as controls, children with typical development. All subjects underwent at least 1 overnight polysomnographic recording (PSG). All recorded data obtained from patients and controls were compared. In children with FXS, all PSG-recorded parameters resulted pathological values compared to those obtained from controls, and in FXS children only, we recorded interictal epileptiform discharges (IEDs), as diffuse or focal spikes and sharp waves, usually singles or in brief runs with intermittent or occasional incidence. A possible link between IEDs and alterations in the circadian sleep-wake cycle may suggest a common dysregulation of the balance between inhibitory and excitatory pathways in these patients. The alteration in sleep pattern in children with FXS may negatively impact the neuropsychological and behavioral functioning, adding increasing burn of the disease on the overall management of these patients. In this regard, treating physicians have to early detect sleep disturbances in their patients for tailored management, in order to prevent adjunctive comorbidities.

Copyright © 2019 Marco Carotenuto et al.

Address: Sleep Lab for Developmental Age, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, University of Campania "Luigi Vanvitelli", Napoli, Italy.; Department of Psychology, Educational and Science and Human Movement, University of Palermo, Palermo, Italy.; Child Neuropsychiatry Unit, Medicine & Surgery Department, University of Parma, Parma, Italy.; Department of Neuropsychiatry, Children's Hospital "G. Salesi", Ospedali Riuniti Ancona, Ancona, Italy.; Department of Pediatrics, University of L'Aquila, L'Aquila, Italy.; Pediatric Clinic, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.; Child Neuropsychiatry Unit, Department of Medicine, Surgery and Odontostomatology, University of Salerno, Italy.; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.; CDR Santa Maria del Pozzo, Somma Vesuviana, Naples, Italy.; Sleep Lab for Developmental Age, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, University of Campania "Luigi Vanvitelli", Napoli, Italy.; Child Neuropsychiatry Unit, Department of Medicine, Surgery and Odontostomatology, University of Salerno, Italy.; Complex Structure of Neuropsychiatry Childhood-Adolescence of Ospedali Riuniti of Foggia, Foggia, Italy.; Department of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.